British Journal of Dermatology

Research Snippets
pp. i-i(1)

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
pp. 659-678(20)
Authors: Scarisbrick, J.J.; Taylor, P.; Holtick, U.; Makar, Y.; Douglas, K.; Berlin, G.; Juvonen, E.; Marshall, S.

Increased expression of aquaporin-3 in the epidermis of DHCR24 knockout mice
pp. 679-684(6)
Authors: Mirza, R.; Hayasaka, S.; Kambe, F.; Maki, K.; Kaji, T.; Murata, Y.; Seo, H.

Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay
pp. 685-690(6)
Authors: Nagasaka, T.; Fujii, Y.; Ishida, A.; Handa, M.; Tanikawa, A.; Amagai, M.; Nishikawa, T.

Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor
pp. 691-697(7)
Authors: Hunger, R.E.; Surovy, A.M.; Hassan, A.S.; Braathen, L.R.; Yawalkar, N.

Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases
pp. 698-704(7)
Authors: Bonifaz, A.; González-Silva, A.; Albrandt-Salmerón, A.; del Carmen Padilla, M.; Saúl, A.; Ponce, R. María

Topical treatment of mild to moderate plaque psoriasis with 0·3% tacrolimus gel and 0·5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression
pp. 705-712(8)
Authors: Vissers, W.H.P.M.; van Vlijmen, I.; van Erp, P.E.J.; de Jong, E.M.G.J.; van de Kerkhof, P.C.M.

Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars
pp. 713-720(8)
Authors: Cheng, B.; Liu, H-W.; Fu, X-B.; Sheng, Z-Y.; Li, J-F.

Demographic and clinical correlates of extent of psoriasis during stable disease and during flares in chronic plaque psoriasis
pp. 721-726(6)
Authors: Osborne, J.E.; Hutchinson, P.E.

Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate
pp. 727-733(7)
Authors: Wiegell, S.R.; Skiveren, J.; Philipsen, P.A.; Wulf, H.C.

The impact of meteorological conditions on patch test results with 12 standard series allergens (fragrances, biocides, topical ingredients)
pp. 734-739(6)
Authors: Uter, W.; Hegewald, J.; Kränke, B.; Schnuch, A.; Gefeller, O.; Pfahlberg, A.

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study
pp. 740-746(7)
Authors: Wiegell, S.R.; Hædersdal, M.; Philipsen, P.A.; Eriksen, P.; Enk, C.D.; Wulf, H.C.

Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders
pp. 747-753(7)
Authors: Kamstrup, M.R.; Ralfkiaer, E.; Skovgaard, G.L.; Gniadecki, R.

Diagnostic criteria for atopic dermatitis: a systematic review
pp. 754-765(12)
Authors: Brenninkmeijer, E.E.A.; Schram, M.E.; Leeflang, M.M.G.; Bos, J.D.; Spuls, Ph.I.

Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women
pp. 766-772(7)
Authors: Pérez-Gómez, B.; Aragonés, N.; Gustavsson, P.; Lope, V.; López-Abente, G.; Pollán, M.

Medical consultations in relation to severity of hand eczema in the general population
pp. 773-777(5)
Authors: Hald, M.; Berg, N.D.; Elberling, J.; Johansen, J.D.

Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas
pp. 778-785(8)
Authors: Kivisaari, A.K.; Kallajoki, M.; Mirtti, T.; McGrath, J.A.; Bauer, J.W.; Weber, F.; Königová, R.; Sawamura, D.; Sato-Matsumura, K.C.; Shimizu, H.; Csikós, M.; Sinemus, K.; Beckert, W.; Kähäri, V-M.

Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial
pp. 786-792(7)
Authors: Koch, C.; Dölle, S.; Metzger, M.; Rasche, C.; Jungclas, H.; Rühl, R.; Renz, H.; Worm, M.

Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists
pp. 793-800(8)
Authors: Collin, B.; Srinathan, S.K.; Finch, T.M.

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study
pp. 801-807(7)
Authors: Peserico, A.; Städtler, G.; Sebastian, M.; Fernandez, R. Suarez; Vick, K.; Bieber, T.

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
pp. 808-817(10)
Authors: Ruzicka, T.; Lynde, C.W.; Jemec, G.B.E.; Diepgen, T.; Berth-Jones, J.; Coenraads, P.J.; Kaszuba, A.; Bissonnette, R.; Varjonen, E.; Holló, P.; Cambazard, F.; Lahfa, M.; Elsner, P.; Nyberg, F.; Svensson, A.; Brown, T.C.; Harsch, M.; Maares, J.

Segregation analysis in X-linked ichthyosis: paternal transmission of the affected X-chromosome
pp. 818-820(3)
Authors: Toral-Lopez, J.; González-Huerta, L.M.; Cuevas-Covarrubias, S.A.

Complex dermoscopic pattern: a potential risk marker for melanoma
pp. 821-824(4)
Authors: Lipoff, J.B.; Scope, A.; Dusza, S.W.; Marghoob, A.A.; Oliveria, S.A.; Halpern, A.C.

Periodontal Ehlers-Danlos syndrome associated with type III and I collagen deficiencies
pp. 825-830(6)
Authors: Mataix, J.; Bañuls, J.; Muñoz, C.; Bermejo, A.; Climent, J.M.

Three novel ATP2C1 mutations in Chinese patients with Hailey-Hailey disease
pp. 831-833(3)
Authors: Zhang, Z.Z.; Liang, Y.H.; Quan, C.; Gao, M.; Xiao, F.L.; Yang, S.; Zhang, X.J.; Zhou, F.S.; Li, W.; Fang, Q.Y.; Shen, Y.J.; Du, W.H.; Mu, Y.Z.; Sui, W.C.; Zhou, L.

Novel mutation in the human hairless gene once more erroneously diagnosed and treated as `alopecia areata'
pp. 834-835(2)
Authors: Roelandt, T.; Kraemer, L.; VanNeste, D.; Lissens, W.; Roseeuw, D.; Christiano, A.M.; Hachem, J.-P.

Skin histopathology and immunopathology are not of prognostic value in dengue haemorrhagic fever
pp. 836-837(2)
Authors: Saadiah, S.; Sharifah, B.I.; Robson, A.; Greaves, M.W.

A cytotoxic analysis of topical antimicrobials on skin substitutes and autograft
pp. 837-838(2)
Authors: Burd, A.; Huang, L.

Indeterminate cell histiocytosis responding to total skin electron beam therapy
pp. 838-840(3)
Authors: Malhommede laRoche, H.; Lai-Cheong, J.E.; Calonje, E.; Davies, M.; Morris, S.; Whittaker, S.J.

Possible molecular pathogenesis for plate-like sebaceous hyperplasia overlying dermatofibroma
pp. 840-842(3)
Authors: Yoneda, K.; Demitsu, T.; Matsuda, Y.; Kubota, Y.

Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis
pp. 842-844(3)
Authors: Tominaga, M.; Ogawa, H.; Takamori, K.

Proton pump inhibitors may trigger vitiligo by rendering melanocytes prone to apoptosis
pp. 844-845(2)
Author: Namazi, M.R.

Prevalence of atopic dermatitis in children younger than 4 years in a demarcated area in central Netherlands: the West Veluwe Study Group
pp. 846-847(2)
Authors: Dirven-Meijer, P.C.; Glazenburg, E.J.; Mulder, P.G.H.; Oranje, A.P.

Comparison of tuberculin skin test and interferon-γ assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-α therapy
pp. 847-849(3)
Authors: Balato, N.; Ayala, F.; Gaudiello, F.; Monfrecola, G.; Cimmino, G.; Ponticiello, A.; Bocchino, M.; Matarese, A.; Sanduzzi, A.

The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17
pp. 849-851(3)
Authors: Ludwig, R.J.; Schindewolf, M.; Lindhoff-Last, E.; Boehncke, W-H.

Linear morphoea with spontaneous fractures
pp. 852-853(2)
Authors: BarreraVigo, M.V.; Torrelo, A.; Hernandez, A.; Gonzalez, G.

Generalized pustular psoriasis and cryptogenic organizing pneumonia
pp. 853-854(2)
Authors: Webber, N.K.; Elston, C.M.; O'Toole, E.A.

The efficacy of oral treatment with pramiconazole in tinea pedis and tinea cruris/corporis: two exploratory phase IIa trials
pp. 854-856(3)
Authors: Decroix, J.; Ausma, J.; Cauwenbergh, G.; Borgers, M.; Wouters, L.

Intravenous immunoglobulin for pyoderma gangrenosum
pp. 856-857(2)
Authors: Kreuter, A.; Reich-Schupke, S.; Stücker, M.; Altmeyer, P.; Gambichler, T.

Amyloid elastosis: a new case studied extensively by electron microscopy and immunohistochemistry
pp. 858-860(3)
Authors: Bocquier, B.; D'Incan, M.; Joubert, J.; Kanitakis, J.; Salavert, M.; Tournilhac, O.; Maitre, F.; Déchelotte, P.; Souteyrand, P.; Estève, E.; Martin, L.

The occurrence of two types of amyloid in the same patient
pp. 860-862(3)
Authors: Koba, S.; Inoue, T.; Otu, M.; Miura, Y.; Misago, N.; Narisawa, Y.

Glucose transporter-1 protein is immunohistochemically expressed in subglottic infantile haemangioma
pp. 862-863(2)
Authors: Liang, M.G.; Maccario, S.; Rahbar, R.; Kozakewich, H.P.W.; Mulliken, J.B.

Persistent supravenous eruption induced by intravenous bortezomib therapy
pp. 863-864(2)
Authors: Mataix, J.; Betlloch, I.; Palmero, F.; Romero, A.

Novel compound heterozygous nonsense and missense ABCA12 mutations lead to nonbullous congenital ichthyosiform erythroderma
pp. 864-867(4)
Authors: Akiyama, M.; Sakai, K.; Hatamochi, A.; Yamazaki, S.; McMillan, J.R.; Shimizu, H.

Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management
pp. 867-869(3)
Authors: Ulmer, A.; Wölbing, F.; Metzler, G.; Schanz, S.; Fierlbeck, G.; Röcken, M.

Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary
pp. 869-870(2)
Authors: Gómez-Outes, A.; Gómez de laBárcena, C.; Martínez-González, J.

News and Notices
pp. 870-872(3)

Corrigendum
pp. 873-873(1)

British Society for Investigative Dermatology Annual Meeting
pp. 874-912(39)